Shenzhen Third People's Hospital
Shenzhen · Infectious Diseases · 3A · NCC
Fudan 2022 · #100 3A · NCC
Overview
Shenzhen Third People's Hospital is a leading Chinese hospital located in Shenzhen, China. It is included in the MedTravelCN Top 100 for its recognized strength in Infectious Diseases and its capacity to receive international patients.
A municipal tertiary hospital focused on infectious disease, host of the national clinical research centre for infectious disease and Shenzhen's main COVID-19 treatment site.
Key information
| Founded | 1985 |
|---|---|
| City | Shenzhen |
| Specialty focus | Infectious Diseases |
| Accreditation | 3A · NCC |
| Fudan 2022 rank | #100 |
Address & location
Leading departments
Ranking trend (Fudan ranking, tier reference)
2021
2022
2023
2024
2025
Tier bands compiled from Fudan China Hospital Ranking releases 2021-2025; for reference only.
Representative experts
- Infectious disease team · Emerging infections and FUO
- Hepatology team · Viral hepatitis and cirrhosis
- TB team · MDR-TB and short-course therapy
- Respiratory team · Severe pneumonia and respiratory support
- Critical care team · Sepsis and ECMO
- Laboratory team · Metagenomic pathogen sequencing
Experts compiled from public sources and hospital websites; availability and titles may change — please verify with the hospital before booking.
News & milestones
National infectious-disease research centre advances
Clinical and translational work covers emerging infections, TB and viral hepatitis.
Main COVID-19 treatment site in Shenzhen
It ran whole wards for critical care and infection control.
Short-course TB therapy and resistance monitoring
Clinical studies and roll-out of short-course MDR-TB regimens.
Genomic surveillance of SARS-CoV-2 variants
Local sequencing and variant tracking were established.
International infectious-disease clinic opened
Care for hepatitis, TB and HIV for foreign patients.
Milestones compiled from credible public reports and official releases; titles are summarized.
International cooperation & exchange
- Joint research and data sharing on emerging infections with Hong Kong and international partners.
- Participation in international COVID-19 and TB trials with publications abroad.
- English and Cantonese consultations plus cross-border follow-up.
International cooperation information compiled from public reports; subject to the hospital's official releases.
University collaboration
Cooperates with universities in medical education and joint research programs.
Research & publications
The national infectious-disease research centre, with concentrated work on emerging infections, TB and liver disease.
Compiled from public sources as of October 2026. Please verify details on the hospital's official website before travel.